Dana Zakalik

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline

Nadine Tung, Judy C. Boughey, Lori J. Pierce et al. · Journal of Clinical Oncology · 2020 · 307 citations · Full text

Study of Sexual Functioning Determinants in Breast Cancer Survivors

Justine J. Speer, Bruce Hillenberg, Dennis Sugrue et al. · The Breast Journal · 2005 · 200 citations · Full text

Breast Oncology, Cancer Management, Gynecology +19

Male BRCA mutation carriers: clinical characteristics and cancer spectrum

Mohammed Ibrahim, Siddhartha Yadav, Foluso Ogunleye et al. · BMC Cancer · 2018 · 106 citations · Full text

Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers

Joanne Kotsopoulos, Jan Lubiński, Pål Møller et al. · Breast Cancer Research and Treatment · 2014 · 97 citations

Contraception, Breast Oncology, Hormonal Contraceptive +12